Doc code: IDS Doc description: Information Disclosure Statement (IDS) Filed PTO/SB/08a (03-15) Approved for use through 07/31/2016. OMB 0651-0031 U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number. Application Number Filing Date INFORMATION DISCLOSURE STATEMENT BY APPLICANT ( Not for submission under 37 CFR 1.99) First Named Inventor Art Unit Examiner Name Attorney Docket Number U.S.PATENTS Examiner Cite Initial* No Kind Issue Date Code1 Pages,Columns,Lines where Name of Patentee or Applicant Relevant Passages or Relevant of cited Document Figures Appear Patent Number 1 If you wish to add additional U.S. Patent citation information please click the Add button. U.S.PATENT APPLICATION PUBLICATIONS Examiner Publication Cite No Initial* Number Kind Publication Code1 Date Pages,Columns,Lines where Name of Patentee or Applicant Relevant Passages or Relevant of cited Document Figures Appear 1 If you wish to add additional U.S. Published Application citation information please click the Add button. FOREIGN PATENT DOCUMENTS Examiner Cite Foreign Document Initial* No Number3 Country Code2 i Kind Publication Code4 Date Name of Patentee or Applicant of cited Document Pages,Columns,Lines where Relevant T5 Passages or Relevant Figures Appear 1 If you wish to add additional Foreign Patent Document citation information please click the Add button NON-PATENT LITERATURE DOCUMENTS Include name of the author (in CAPITAL LETTERS), title of the article (when appropriate), title of the item Examiner Cite (book, magazine, journal, serial, symposium, catalog, etc), date, pages(s), volume-issue number(s), Initials* No publisher, city and/or country where published. T5 EFS Web 2.1.17 Application Number Filing Date INFORMATION DISCLOSURE STATEMENT BY APPLICANT ( Not for submission under 37 CFR 1.99) First Named Inventor Art Unit Examiner Name Attorney Docket Number 1 If you wish to add additional non-patent literature document citation information please click the Add button EXAMINER SIGNATURE Examiner Signature Date Considered *EXAMINER: Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through a citation if not in conformance and not considered. Include copy of this form with next communication to applicant. 1 See Kind Codes of USPTO Patent Documents at www.USPTO.GOV or MPEP 901.04. 2 Enter office that issued the document, by the two-letter code (WIPO Standard ST.3). 3 For Japanese patent documents, the indication of the year of the reign of the Emperor must precede the serial number of the patent document. 4 Kind of document by the appropriate symbols as indicated on the document under WIPO Standard ST.16 if possible. 5 Applicant is to place a check mark here if English language translation is attached. EFS Web 2.1.17 Application Number Filing Date INFORMATION DISCLOSURE STATEMENT BY APPLICANT ( Not for submission under 37 CFR 1.99) First Named Inventor Art Unit Examiner Name Attorney Docket Number CERTIFICATION STATEMENT Please see 37 CFR 1.97 and 1.98 to make the appropriate selection(s): That each item of information contained in the information disclosure statement was first cited in any communication from a foreign patent office in a counterpart foreign application not more than three months prior to the filing of the information disclosure statement. See 37 CFR 1.97(e)(1). OR That no item of information contained in the information disclosure statement was cited in a communication from a foreign patent office in a counterpart foreign application, and, to the knowledge of the person signing the certification after making reasonable inquiry, no item of information contained in the information disclosure statement was known to any individual designated in 37 CFR 1.56(c) more than three months prior to the filing of the information disclosure statement. See 37 CFR 1.97(e)(2). See attached certification statement. The fee set forth in 37 CFR 1.17 (p) has been submitted herewith. A certification statement is not submitted herewith. SIGNATURE A signature of the applicant or representative is required in accordance with CFR 1.33, 10.18. Please see CFR 1.4(d) for the form of the signature. Signature Name/Print Date (YYYY-MM-DD) Registration Number This collection of information is required by 37 CFR 1.97 and 1.98. The information is required to obtain or retain a benefit by the public which is to file (and by the USPTO to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.14. This collection is estimated to take 1 hour to complete, including gathering, preparing and submitting the completed application form to the USPTO. Time will vary depending upon the individual case. Any comments on the amount of time you require to complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, U.S. Patent and Trademark Office, U.S. Department of Commerce, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR COMPLETED FORMS TO THIS ADDRESS. SEND TO: Commissioner for Patents, P.O. Box 1450, Alexandria, VA 22313-1450. EFS Web 2.1.17 Privacy Act Statement The Privacy Act of 1974 (P.L. 93-579) requires that you be given certain information in connection with your submission of the attached form related to a patent application or patent. Accordingly, pursuant to the requirements of the Act, please be advised that: (1) the general authority for the collection of this information is 35 U.S.C. 2(b)(2); (2) furnishing of the information solicited is voluntary; and (3) the principal purpose for which the information is used by the U.S. Patent and Trademark Office is to process and/or examine your submission related to a patent application or patent. If you do not furnish the requested information, the U.S. Patent and Trademark Office may not be able to process and/or examine your submission, which may result in termination of proceedings or abandonment of the application or expiration of the patent. The information provided by you in this form will be subject to the following routine uses: 1. The information on this form will be treated confidentially to the extent allowed under the Freedom of Information Act (5 U.S.C. 552) and the Privacy Act (5 U.S.C. 552a). Records from this system of records may be disclosed to the Depa